Elanix Biotechnologies

OverviewSuggest Edit

Elanix Biotechnologies develops and commercializes products for acute wound care, dermatological and gynecological applications. The Company develops and markets progenitor cell-based products that are used to regenerate tissue and promote healing in the treatment of burns, and gynecological and dermatological conditions. Its products include GYNrepair, a cream for genital external mucosa, and SKINrepair, a cream for skin that protects against external aggressions. Elanix Biotechnologies is also developing FirstCover, an acute wound care tissue engineering product that is used to provide protection and healing for burns, and trauma and plastic surgery. The Company offers cell technology services as well. 

TypePublic
Founded2012
HQPotsdam, DE
Websiteelanixbiotechnologies.com

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)11(+23%)
Revenue (FY, 2017)€328.1 K(+5171%)

Elanix Biotechnologies Office Locations

Elanix Biotechnologies has offices in Potsdam, Berlin and Nyon
Potsdam, DE (HQ)
22 Domstraße
Berlin, DE
32 Kurfürstendamm
Nyon, CH
10 Chemin du Joran
Show all (3)

Elanix Biotechnologies Financials and Metrics

Elanix Biotechnologies Revenue

Embed Graph
View revenue for all periods
Elanix Biotechnologies 's revenue was reported to be €328.15 k in FY, 2017 which is a 5170.6% increase from the previous period.
EUR

Revenue (FY, 2017)

328.1k

Revenue growth (FY, 2016 - FY, 2017), %

5170.6%

Gross profit (FY, 2017)

170.5k

Gross profit margin (FY, 2017), %

52%

Net income (FY, 2017)

3.8m

EBIT (FY, 2017)

4.4m

Cash (31-Dec-2017)

212.2k
EURFY, 2016FY, 2017

Revenue

6.2k328.1k

Revenue growth, %

5171%

Cost of goods sold

3.5k157.6k

Gross profit

2.7k170.5k
EURFY, 2016FY, 2017

Cash

73.6k212.2k

Accounts Receivable

140.0201.5k

Inventories

33.5k138.7k

Current Assets

177.6k1.3m
EURFY, 2016FY, 2017

Cash From Operating Activities

(823.9k)(3.8m)

Purchases of PP&E

(19.0k)(35.3k)

Cash From Investing Activities

(131.5k)(35.3k)

Long-term Borrowings

(597.4k)(767.7k)
EURY, 2017

Revenue/Employee

36.5k

Financial Leverage

1.4 x
Show all financial metrics

Elanix Biotechnologies Revenue Breakdown

Embed Graph

Elanix Biotechnologies revenue breakdown by business segment: 79.6% from Selling Products and 20.4% from Licences

Elanix Biotechnologies Online and Social Media Presence

Embed Graph

Elanix Biotechnologies Blogs

NOVEMBER BUSINESS UPDATE (ENG, DE, FR)

Ladies and Gentlemen, The 2018 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe congress in Berlin was very successful for Elanix’ GYNrepair® team. The DGGG congress was a great opportunity for us to showcase our technology and offer congress participants the possibility to get more informatio…

October Business Update (ENG, DE, FR)

Ladies and Gentlemen, As of October 1st, we formally closed a capital increase. A total of 301,763 shares were placed at a subscription price of EUR 2.75 resulting in gross proceeds of EUR 829,848. These gross process will be used to finance the company’s growth strategy and the launch of our new Ad…

Elanix Biotechnologies Frequently Asked Questions

  • When was Elanix Biotechnologies founded?

    Elanix Biotechnologies was founded in 2012.

  • How many employees does Elanix Biotechnologies have?

    Elanix Biotechnologies has 11 employees.

  • What is Elanix Biotechnologies revenue?

    Latest Elanix Biotechnologies annual revenue is €328.1 k.

  • What is Elanix Biotechnologies revenue per employee?

    Latest Elanix Biotechnologies revenue per employee is €29.8 k.

  • Who are Elanix Biotechnologies competitors?

    Competitors of Elanix Biotechnologies include E-Qure, InspireMD and Soligenix.

  • Where is Elanix Biotechnologies headquarters?

    Elanix Biotechnologies headquarters is located at 22 Domstraße, Potsdam.

  • Where are Elanix Biotechnologies offices?

    Elanix Biotechnologies has offices in Potsdam, Berlin and Nyon.

  • How many offices does Elanix Biotechnologies have?

    Elanix Biotechnologies has 3 offices.